Metraipolis › archive › dc_7f579773df71

CEBPD may function as a molecular indicator of fibrotic severity and negative regulator of fibrosis in uterine leiomyoma through regulating EMT progression — Europe PMC PMID:42239515

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42239515
DOI
10.3389/fphar.2026.1839523
License (as archived)
solo-consultazione
Archived
2026-11-01T14:15:26.679Z
SHA-256 of the archived text
837cbd178a70ca71af33c354fc0e77d8125f2052a678e538f6a5ec2550c0fe3b
Stable URL of this page
https://metraipolis.com/documento/dc_7f579773df71

How to cite

CEBPD may function as a molecular indicator of fibrotic severity and negative regulator of fibrosis in uterine leiomyoma through regulating EMT progression — Europe PMC PMID:42239515 — Europe PMC (en), https://europepmc.org/article/MED/42239515 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7f579773df71 (Metraipolis archive dc_7f579773df71, sha256 837cbd178a70ca71af33c354fc0e77d8125f2052a678e538f6a5ec2550c0fe3b)
BibTeX
@misc{dc7f579773df71,
  title = {CEBPD may function as a molecular indicator of fibrotic severity and negative regulator of fibrosis in uterine leiomyoma through regulating EMT progression — Europe PMC PMID:42239515},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42239515},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7f579773df71; sha256 837cbd178a70ca71af33c354fc0e77d8125f2052a678e538f6a5ec2550c0fe3b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42239515. Agents can read the archived copy with the MCP tool read_document.